BIODESIX INC (BDSX) Form 10-Q Quarterly Reports
BIODESIX INC (BDSX) is a publicly traded company on the Nasdaq, categorized under SIC 8071 (Services-Medical Laboratories). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BDSX
CIK: 1439725
Exchange: Nasdaq
SIC 8071: Services-Medical Laboratories
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerMathieu Groh
Audit LocationDenver, Colorado, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-02 | 2026-09-30 | FORM 4 | 0000905148-26-004336 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-12 | FORM 4 | 0000905148-26-003641 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | FORM 4 | 0000905148-26-003599 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001193125-26-335036 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001193125-26-335010 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | FORM 4 | 0000905148-26-003146 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-18 | — | SCHEDULE 13G Filing | 0001213900-26-070194 | View SEC Doc Filr Page |
| 424B3 | 2026-06-01 | — | 424B3 | 0001193125-26-248913 | View SEC Doc Filr Page |
| EFFECT | 2026-05-29 | — | EFFECT Filing | 9999999995-26-001816 | View SEC Doc Filr Page |
| CORRESP | 2026-05-27 | — | CORRESP Filing | 0001193125-26-241910 | View SEC Doc Filr Page |
| UPLOAD | 2026-05-26 | — | UPLOAD Filing | 0000000000-26-005336 | View SEC Doc Filr Page |
| S-3 | 2026-05-21 | — | S-3 | 0001193125-26-234611 | View SEC Doc Filr Page |
| 8-K | 2026-05-20 | 2026-05-19 | 8-K | 0001193125-26-232631 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001193125-26-226566 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-08 | — | SCHEDULE 13G/A Filing | 0001213900-26-053983 | View SEC Doc Filr Page |
| 10-Q | 2026-05-04 | 2026-03-31 | 10-Q | 0001193125-26-203960 | View SEC Doc Filr Page |
| 8-K | 2026-05-04 | 2026-05-04 | 8-K | 0001193125-26-203936 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-28 | — | SCHEDULE 13G Filing | 0001493152-26-019343 | View SEC Doc Filr Page |
| ARS | 2026-04-09 | 2025-12-31 | ARS | 0001193125-26-149700 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-09 | — | DEFA14A | 0001193125-26-149694 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-09 | 2026-05-19 | DEF 14A | 0001193125-26-149633 | View SEC Doc Filr Page |
| 4 | 2026-04-02 | 2026-03-31 | FORM 4 | 0000905148-26-001495 | View SEC Doc Filr Page |
| 10-K | 2026-02-26 | 2025-12-31 | 10-K | 0001193125-26-076547 | View SEC Doc Filr Page |
| 8-K | 2026-02-26 | 2026-02-26 | 8-K | 0001193125-26-076521 | View SEC Doc Filr Page |
| 4 | 2026-02-23 | 2026-02-20 | FORM 4 | 0000905148-26-000987 | View SEC Doc Filr Page |